Funds and ETFs Hangzhou Tigermed Consulting Co., Ltd
Equities
300347
CNE100001KV8
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59.69 CNY | -0.10% | +0.98% | +8.59% |
Apr. 25 | Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 | MT |
Apr. 25 | Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
ETFs positioned on Hangzhou Tigermed Consulting Co., Ltd
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.98% | 1 M€ | -9.86% | - | |
0.69% | 0 M€ | -12.22% | - | |
0.18% | 35 M€ | -5.85% | - | |
0.02% | 2 M€ | -.--% | ||
0.02% | 7 M€ | -.--% | - | |
0.02% | 4 M€ | -11.56% | ||
0.01% | 0 M€ | +3.95% | - | |
0.00% | 0 M€ | +8.81% | - | |
0.00% | 0 M€ | +5.91% | - | |
0.00% | 0 M€ | +8.01% | - | |
0.00% | 0 M€ | +7.24% | - | |
0.00% | 4 M€ | -4.41% | - | |
0.00% | 0 M€ | +8.24% | - | |
0.00% | 0 M€ | +3.63% | - | |
0.00% | 0 M€ | +5.63% | - | |
0.00% | 0 M€ | +5.79% | - | |
0.00% | 0 M€ | +2.80% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.59% | 6.7B | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- 300347 Stock
- Funds and ETFs Hangzhou Tigermed Consulting Co., Ltd